Navigation Links
Sanofi Announces Positive Phase 3 Data for Once-Daily Lixisenatide for Type 2 Diabetes
Date:6/22/2013

-- change was -0.77% with lixisenatide plus standard of care compared with -0.29% with placebo plus standard of care (p<0.0001). The reduction in BHG exposure between lixisenatide plus standard of care and placebo plus standard of care were similar (adjusted LS mean change for AUC24h -234 mg/dl*h vs. -198 mg/dl*h [NS]), but PPG exposure was reduced more with lixisenatide plus standard of care compared with placebo plus standard of care (adjusted LS mean change -378 mg/dl*h vs. -180 mg/dl *h, p<0.0001).

The three Phase 3 studies included in this analysis were part of the GetGoal clinical program and included GetGoal-L, GetGoal-L Asia and GetGoal Duo1. The most common adverse events were nausea, vomiting, diarrhea and symptomatic hypoglycemia which are detailed in the following chart. GetGoal-L

GetGoal-L Asia

GetGoal Duo1Lixisenatide

Placebo

Lixisenatide

Placebo

Lixisenatide

PlaceboDiarrhea

7.3%

5.4%

6.5%

2.5%

6.7%

3.1%Nausea

26.2%

8.4%

39.6%

4.5%

27.4%

4.9%Vomiting

8.2%

0.6%

18.2%

1.9%

9.4%

1.3%Symptomatic

Hypoglycemia

27.7%

21.6%

32.6%

47.2%*

28.3%

21.6%*

22.4%

13.4%Severe

Hypoglycemia

1.2%

0%

-

-

0.4%

0%* Sulfonylurea added to lixisenatide plus basal insulin

"Sanofi is committed to addressing the needs of the 26 million people in the U.S. who are living with diabetes," said Dennis Urbaniak, Vice President and Head of U.S. Diabetes Patient Centered Unit, Sanofi US. "We are encouraged by these results that suggest the potential for lixisenatide to be the first once-daily prandial GLP-1 receptor agonist for the treatment of adults with type 2 diabetes in
'/>"/>

SOURCE Sanofi
Copyright©2012 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6

Related medicine technology :

1. Sanofi Pasteur Presents Pediatric Data on Investigational Quadrivalent Influenza Vaccine
2. Sanofi US Launches Collaborate Activate Innovation Challenge
3. Sanofi Pasteur to add 2D barcode to six more vaccines
4. Sanofi and Regeneron Announce Publication of Phase 2 Results with LDL Cholesterol-Lowering PCSK9 Antibody in the New England Journal of Medicine
5. Sanofi and Regeneron Announce Patient Enrollment in Cardiovascular Outcomes Trial with Antibody to PCSK9 for Hypercholesterolemia
6. Sanofi and T1D Exchange to Launch Worldwide Study to Investigate Factors for Optimal Care for Young People with Diabetes
7. Sanofi Donates $500,000 to Hurricane Sandy for Immediate and Long-Term Relief Efforts
8. Phase II Trial of Sanofi JAK2 Inhibitor in Myelofibrosis Met Primary Endpoint
9. Sanofi Launches Breakthrough Technology for Cardiovascular and Vascular Surgery Procedures
10. Zacks Bull and Bear of the Day Highlights: Smithfield Foods, Logitech International, Sanofi, Isis Pharmaceuticals and Aegerion Pharmaceuticals
11. Sanofi New Drug Application for Lixisenatide Accepted for Review by FDA
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:1/15/2014)... THOUSAND OAKS, Calif. , Jan. 15, 2014 ... and Amgen (NASDAQ: AMGN ) announced ... to jointly discover and validate new therapeutic targets ... (IBD), a chronic disorder that affects millions worldwide. ...
(Date:1/15/2014)... GARDENS, Fla. , Jan. 15, 2014  In an unprecedented effort ... and TB in ambulances and other transport vehicles, an advanced and ... by rescue personnel for the first time. In ... contact with these deadly pathogens, West Palm Beach ...
(Date:1/15/2014)... 2014  According to Millennium Research Group (MRG), the ... the United States and European ... expand moderately through 2022, with embolization particles representing ... interest in drug-eluting beads (DEBs) and radioembolization spheres ...
Breaking Medicine Technology:Mass. General, Broad Institute and Amgen Will Work to Discover New Drugs for Inflammatory Bowel Disease 2Mass. General, Broad Institute and Amgen Will Work to Discover New Drugs for Inflammatory Bowel Disease 3Mass. General, Broad Institute and Amgen Will Work to Discover New Drugs for Inflammatory Bowel Disease 4Superbugs No Longer Ride In Rescue Vehicles 2US and European Transcatheter Embolization and Occlusion Device Market to Surpass $1.6 Billion by 2022 2US and European Transcatheter Embolization and Occlusion Device Market to Surpass $1.6 Billion by 2022 3
(Date:4/17/2014)... AURORA, Colo. (April 17, 2014) Two recent ... Medicine researcher and colleagues may help scientists develop ... virus, Yellow fever, Japanese encephalitis and other disease-causing ... of biochemistry and molecular genetics at the School ... the Howard Hughes Medical Institute, and colleagues recently ...
(Date:4/17/2014)... military personnel who served in Iraq and Afghanistan ... injury (TBI) were compared to military personnel without ... Differences in measures of overall disability, cognitive function, ... are reported in an article in Journal ... Ann Liebert, Inc., publishers. The article is available ...
(Date:4/17/2014)... IL, April 17, 2014-- Colic affects about one in ... for numerous pediatric visits during the first several months ... colic symptoms was showing promise; however, the April 1, ... (BMJ2014;348:g2107; Sung, Valerie) reported on a study, "Probiotics and ... L reuteri for infant colic did ...
(Date:4/17/2014)... (SACRAMENTO, Calif.) An international team led by researchers ... protein complex, which plays a key role in cell ... process. This is the first time the complex has ... could make cyclin B1/Cdk1 an excellent target to control ... medicine. The research was published online today in the ...
(Date:4/17/2014)... uncommon these days to find a colored ribbon representing a ... cancer. But what color ribbon does one think of with ... color, for many suffering from the disease, black may be ... study consisting of lung cancer patients, primarily smokers between the ... light on the stigma often felt by these patients, the ...
Breaking Medicine News(10 mins):Health News:CU researchers discover target for treating dengue fever 2Health News:Long-term effects of battle-related 'blast plus impact' concussive TBI in US military 2Health News:New study says probiotic use for infant colic is not effective in reducing symptoms 2Health News:Dual role: Key cell division proteins also power up mitochondria 2Health News:Unraveling the 'black ribbon' around lung cancer 2
... time you leave your home? You may not be ... University of British Columbia and Vancouver Coastal Health Research ... who, without apparent brain damage or cognitive impairment, is ... that there are many others in the general population ...
... provider of,business process outsourcing (BPO) solutions for health ... its board of directors. Pym was,singled out for ... companies on growth and strategic planning issues. Following ... Ehrmann LLP as,partner, Mr. Pym formed the Bruce ...
... the brink of phenomenal,growth, the administration of Physicians Health ... grow with it while it,created an overarching brand campaign ... that partnership with Blue Clover -- a versatile, fast,moving ... -- and named,it Agency of Record as of July ...
... discontinue several key anesthesia systems, DRE Medical Equipment is ... ... Louisville, KY (Vocus) ... http://www.dremed.com [surgical and medical equipment supplier], recently ...
... Ever "Pulse of the Industry Report" at,Conference, ... kicks off with the release of the first ... Medical Technology" report, nearly 20 next,generation company presentations, ... of the world,s most advanced medical technology, surgical ...
... our healing? Since 2005 DreamHealer has collected data on ... and visualizations. The results were analyzed (by Statistics Made ... testing. With a sample base of over 2500 participants ... do healing visualizations showed improvement in their health. 30% ...
Cached Medicine News:Health News:Getting lost -- a newly discovered developmental brain disorder 2Health News:Adaptis Names Bruce Pym to the Board Of Directors 2Health News:Physicians Health Choice Hires Blue Clover as Agency of Record 2Health News:DRE Medical Equipment Offers Valuable Discounts to GE Healthcare Customers 2Health News:AdvaMed 2008 Opens Showcasing Latest Medical Technologies with Innovation Alley Exhibit and Next Generation Company Presentations 2Health News:Dreamhealer Encourages Global Healing of Those Affected by Disasters or Illness 2
... The Soft Boston Scoliosis Brace™ ... support is a lightweight, soft, ... designed for maximum comfort. ... is constructed of non-cracking orthopedic ...
An indirect immunofluorescence antibody test for the qualitative and semi-quantitative detection of endomysial antibodies (EMA) in human serum as an aid in the diagnosis of celiac disease and dermati...
Urethrotome - non-optical...
Bougie Urethrotomes for slitting the female urethra and for meatus stenosis in males...
Medicine Products: